ARQL News and Press, ArQule Inc. From 12/23/19

This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited. We analyze the attractiveness and profitability of each spread going forward and indicate the trading position or...

Biotech, hands down, wins the race for out-performance in the healthcare sector. Delivering new, valuable medicines has proven to be a winning strategy, even if the growth in their stocks is based on the hope of future drugs. However, this list focuses on the top 10 healthcare stocks in 2019, n...

In the spirit of the season, this is a view of Merck's ( MRK ) past, present, and future along the lines of Charles Dickens: A Christmas Carol. The past is the company's downfall from the Vioxx situation and recovery from the accomplishments of achieving multiple new blockbusters. The presen...

NEW YORK, NY / ACCESSWIRE / December 21, 2019 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Care.com, Inc. (NYSE:CRCM) The investigation concerns whether Care.com and its board of directors violated the federal securities laws a...

Shares of Aptose Biosciences (NASDAQ: APTO) were jumping 14% higher as of 3:14 p.m. EST on Wednesday. The clinical-stage biotech announced on Tuesday that its public stock offering of more than 16 million shares would be priced at $4 per share. Aptose's decision to raise money through a sto...

Merck (NYSE: MRK )  commences a cash tender offer to purchase all outstanding common shares of ArQule (NASDAQ: ARQL ). More news on: Merck & Co., Inc., ArQule, Inc., Healthcare stocks news, Read more ...

Merger activity decreased with four new deals announced and two deals closing. Deal Statistics: New Deals: The acquisition of Diplomat Pharmacy (DPLO) by OptumRx for $300 million or $4.00 per share in cash. The acquisition of Synthorx (THOR) by Sanofi (SNY) for $2.35 billio...

This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited. We analyze the attractiveness and profitability of each spread going forward and indicate the trading position ...

NEW YORK, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: ArQule, Inc. (NASDAQ: ARQL) The investigation concerns whether ArQule and its board of directors violated the federal securities laws and/o...

Merck ( MRK ) had announced that it would purchase ArQule ( ARQL ) for a total of $2.7 billion or $20 per share in cash. The main goal for this acquisition was that Merck could add a precision medicine oncology biotech to its portfolio. This acquisition should help the oncology portfol...